Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 238

1.

The FDA and Adulterated Supplements-Dereliction of Duty.

Cohen PA.

JAMA Netw Open. 2018 Oct 5;1(6):e183329. doi: 10.1001/jamanetworkopen.2018.3329. No abstract available.

PMID:
30646231
2.

Cervical cancer.

Cohen PA, Jhingran A, Oaknin A, Denny L.

Lancet. 2019 Jan 12;393(10167):169-182. doi: 10.1016/S0140-6736(18)32470-X. Review.

PMID:
30638582
3.

Acceptability and utility of, and preference for wearable activity trackers amongst non-metropolitan cancer survivors.

Hardcastle SJ, Galliott M, Lynch BM, Nguyen NH, Cohen PA, Mohan GR, Johansen NJ, Saunders C.

PLoS One. 2018 Dec 31;13(12):e0210039. doi: 10.1371/journal.pone.0210039. eCollection 2018.

4.

Wearable Activity Technology And Action-Planning (WATAAP) to promote physical activity in cancer survivors: Randomised controlled trial protocol.

Maxwell-Smith C, Cohen PA, Platell C, Tan P, Levitt M, Salama P, Makin GB, Tan J, Salfinger S, Kader Ali Mohan GR, Kane RT, Hince D, Jiménez-Castuera R, Hardcastle SJ.

Int J Clin Health Psychol. 2018 May-Aug;18(2):124-132. doi: 10.1016/j.ijchp.2018.03.003. Epub 2018 Apr 14.

5.

Mechanisms underlying acquired platinum resistance in high grade serous ovarian cancer - a mini review.

Binju M, Padilla MA, Singomat T, Kaur P, Suryo Rahmanto Y, Cohen PA, Yu Y.

Biochim Biophys Acta Gen Subj. 2019 Feb;1863(2):371-378. doi: 10.1016/j.bbagen.2018.11.005. Epub 2018 Nov 10. Review.

PMID:
30423357
6.

Prohibited Stimulants in Dietary Supplements After Enforcement Action by the US Food and Drug Administration.

Cohen PA, Wen A, Gerona R.

JAMA Intern Med. 2018 Dec 1;178(12):1721-1723. doi: 10.1001/jamainternmed.2018.4846. No abstract available.

PMID:
30422217
7.

RANZCOG Fellows' adherence to guidelines following cytological prediction of cervical adenocarcinoma-in-situ: Cause for concern?

Powell A, Cohen PA, Spilsbury K, Steel N, Blomfield P.

Aust N Z J Obstet Gynaecol. 2018 Oct 4. doi: 10.1111/ajo.12886. [Epub ahead of print]

PMID:
30284744
8.

Probiotic Safety-No Guarantees.

Cohen PA.

JAMA Intern Med. 2018 Dec 1;178(12):1577-1578. doi: 10.1001/jamainternmed.2018.5403. No abstract available.

PMID:
30242393
9.

The stimulant higenamine in weight loss and sports supplements.

Cohen PA, Travis JC, Keizers PHJ, Boyer FE, Venhuis BJ.

Clin Toxicol (Phila). 2018 Sep 6:1-6. doi: 10.1080/15563650.2018.1497171. [Epub ahead of print]

PMID:
30188222
10.

'Eminence based medicine' and the Goldilocks principle: Authors' reply to 'Working hours of obstetrics and gynaecology trainees in Australia and New Zealand'.

Acton JN, Tucker PE, Bulsara MK, Cohen PA.

Aust N Z J Obstet Gynaecol. 2018 Aug;58(4):E9-E10. doi: 10.1111/ajo.12843. Epub 2018 Jun 27. No abstract available.

PMID:
29947120
11.

Knowledge, attitudes, and practice of oncologists and oncology health care providers in promoting physical activity to cancer survivors: an international survey.

Hardcastle SJ, Kane R, Chivers P, Hince D, Dean A, Higgs D, Cohen PA.

Support Care Cancer. 2018 May 8. doi: 10.1007/s00520-018-4230-1. [Epub ahead of print]

PMID:
29740694
12.

Health-related quality of life and pelvic floor dysfunction in advanced-stage ovarian cancer survivors: associations with objective activity behaviors and physiological characteristics.

Schofield C, Newton RU, Cohen PA, Galvão DA, McVeigh JA, Mohan GR, Tan J, Salfinger SG, Straker LM, Peddle-McIntyre CJ.

Support Care Cancer. 2018 Jul;26(7):2239-2246. doi: 10.1007/s00520-018-4069-5. Epub 2018 Feb 1.

PMID:
29392481
13.

Reply to S.C. Adams et al, C. Lopez et al, and R.U. Newton et al.

Hardcastle SJ, Cohen PA.

J Clin Oncol. 2018 Mar 20;36(9):928-930. doi: 10.1200/JCO.2017.76.8218. Epub 2018 Jan 26. No abstract available.

PMID:
29373095
14.

Activity Behaviors and Physiological Characteristics of Women With Advanced-Stage Ovarian Cancer: A Preliminary Cross-sectional Investigation.

Schofield C, Newton RU, Cohen PA, Galvão DA, McVeigh JA, Hart NH, Mohan GR, Tan J, Salfinger SG, Straker LM, Peddle-McIntyre CJ.

Int J Gynecol Cancer. 2018 Mar;28(3):604-613. doi: 10.1097/IGC.0000000000001197.

PMID:
29369120
15.

Investigating barriers to genetic counseling and germline mutation testing in women with suspected hereditary breast and ovarian cancer syndrome and Lynch syndrome.

Shaw J, Bulsara C, Cohen PA, Gryta M, Nichols CB, Schofield L, O'Sullivan S, Pachter N, Hardcastle SJ.

Patient Educ Couns. 2018 May;101(5):938-944. doi: 10.1016/j.pec.2017.12.011. Epub 2017 Dec 12.

PMID:
29273311
16.

Advanced Training of Gynecologic Surgeons and Incidence of Intraoperative Complications after Total Laparoscopic Hysterectomy: A Retrospective Study of More Than 2000 Cases at a Single Institution.

McDonnell RM, Hollingworth JL, Chivers P, Cohen PA, Salfinger SG.

J Minim Invasive Gynecol. 2018 Jul - Aug;25(5):810-815. doi: 10.1016/j.jmig.2017.12.005. Epub 2017 Dec 15.

PMID:
29253636
17.

Do Groin Drains Reduce Postoperative Morbidity in Women Undergoing Inguinofemoral Lymphadenectomy for Vulvar Cancer?

Pontre J, Harding J, Chivers P, Loughlin L, Leung Y, Salfinger SG, Tan J, Mohan GR, Cohen PA.

Int J Gynecol Cancer. 2018 Jan;28(1):183-187. doi: 10.1097/IGC.0000000000001146.

PMID:
29252926
18.

Outcomes in women undergoing robotic-assisted laparoscopic hysterectomy compared to conventional laparoscopic hysterectomy at a tertiary hospital in Western Australia.

Rajadurai VA, Tan J, Salfinger SG, Cohen PA.

Aust N Z J Obstet Gynaecol. 2018 Aug;58(4):443-448. doi: 10.1111/ajo.12749. Epub 2017 Nov 23.

PMID:
29168558
19.

Snowball Earth climate dynamics and Cryogenian geology-geobiology.

Hoffman PF, Abbot DS, Ashkenazy Y, Benn DI, Brocks JJ, Cohen PA, Cox GM, Creveling JR, Donnadieu Y, Erwin DH, Fairchild IJ, Ferreira D, Goodman JC, Halverson GP, Jansen MF, Le Hir G, Love GD, Macdonald FA, Maloof AC, Partin CA, Ramstein G, Rose BEJ, Rose CV, Sadler PM, Tziperman E, Voigt A, Warren SG.

Sci Adv. 2017 Nov 8;3(11):e1600983. doi: 10.1126/sciadv.1600983. eCollection 2017 Nov.

20.

Questioning the value of margin status in treated cervical precancer.

Cohen PA.

Lancet Oncol. 2017 Dec;18(12):1565-1566. doi: 10.1016/S1470-2045(17)30839-2. Epub 2017 Nov 7. No abstract available. Erratum in: Lancet Oncol. 2018 Jan;19(1):e8.

PMID:
29126707
21.

Synthesis and Immunological Evaluation of a Multicomponent Cancer Vaccine Candidate Containing a Long MUC1 Glycopeptide.

Supekar NT, Lakshminarayanan V, Capicciotti CJ, Sirohiwal A, Madsen CS, Wolfert MA, Cohen PA, Gendler SJ, Boons GJ.

Chembiochem. 2018 Jan 18;19(2):121-125. doi: 10.1002/cbic.201700424. Epub 2017 Nov 30.

22.

Four experimental stimulants found in sports and weight loss supplements: 2-amino-6-methylheptane (octodrine), 1,4-dimethylamylamine (1,4-DMAA), 1,3-dimethylamylamine (1,3-DMAA) and 1,3-dimethylbutylamine (1,3-DMBA).

Cohen PA, Travis JC, Keizers PHJ, Deuster P, Venhuis BJ.

Clin Toxicol (Phila). 2018 Jun;56(6):421-426. doi: 10.1080/15563650.2017.1398328. Epub 2017 Nov 8.

PMID:
29115866
23.

Scientific Trials-In the Laboratories, Not the Courts.

Bagley N, Carroll AE, Cohen PA.

JAMA Intern Med. 2018 Jan 1;178(1):7-8. doi: 10.1001/jamainternmed.2017.5730. No abstract available.

PMID:
29114742
24.

Factors influencing non-participation in an exercise program and attitudes towards physical activity amongst cancer survivors.

Hardcastle SJ, Maxwell-Smith C, Kamarova S, Lamb S, Millar L, Cohen PA.

Support Care Cancer. 2018 Apr;26(4):1289-1295. doi: 10.1007/s00520-017-3952-9. Epub 2017 Oct 31.

PMID:
29090387
25.

Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer.

Garsed DW, Alsop K, Fereday S, Emmanuel C, Kennedy CJ, Etemadmoghadam D, Gao B, Gebski V, Garès V, Christie EL, Wouters MCA, Milne K, George J, Patch AM, Li J, Arnau GM, Semple T, Gadipally SR, Chiew YE, Hendley J, Mikeska T, Zapparoli GV, Amarasinghe K, Grimmond SM, Pearson JV, Waddell N, Hung J, Stewart CJR, Sharma R, Allan PE, Rambau PF, McNally O, Mileshkin L, Hamilton A, Ananda S, Grossi M, Cohen PA, Leung YC, Rome RM, Beale P, Blomfield P, Friedlander M, Brand A, Dobrovic A, Köbel M, Harnett P, Nelson BH, Bowtell DDL, deFazio A; Nadia Traficante, for the Australian Ovarian Cancer Study Group.

Clin Cancer Res. 2018 Feb 1;24(3):569-580. doi: 10.1158/1078-0432.CCR-17-1621. Epub 2017 Oct 23.

PMID:
29061645
26.

A Physiological Profile of Ovarian Cancer Survivors to Inform Tailored Exercise Interventions and the Development of Exercise Oncology Guidelines.

Schofield C, Newton RU, Galvão DA, Cohen PA, Peddle-McIntyre CJ.

Int J Gynecol Cancer. 2017 Sep;27(7):1560-1567. doi: 10.1097/IGC.0000000000001044. Review.

PMID:
29036032
27.

Effective Physical Activity Promotion to Survivors of Cancer Is Likely to Be Home Based and to Require Oncologist Participation.

Hardcastle SJ, Cohen PA.

J Clin Oncol. 2017 Nov 10;35(32):3635-3637. doi: 10.1200/JCO.2017.74.6032. Epub 2017 Sep 15. No abstract available.

PMID:
28915086
28.

Excisional treatment in women with cervical adenocarcinoma in situ (AIS): a prospective randomised controlled non-inferiority trial to compare AIS persistence/recurrence after loop electrosurgical excision procedure with cold knife cone biopsy: protocol for a pilot study.

Cohen PA, Brand A, Sykes P, Wrede DCH, McNally O, Eva L, Rao A, Campion M, Stockler M, Powell A, Codde J, Bulsara MK, Anderson L, Leung Y, Farrell L, Stoyles P.

BMJ Open. 2017 Aug 28;7(8):e017576. doi: 10.1136/bmjopen-2017-017576.

29.

Controlled hydroxyapatite biomineralization in an ~810 million-year-old unicellular eukaryote.

Cohen PA, Strauss JV, Rooney AD, Sharma M, Tosca N.

Sci Adv. 2017 Jun 28;3(6):e1700095. doi: 10.1126/sciadv.1700095. eCollection 2017 Jun.

30.

Tbet and IL-36γ cooperate in therapeutic DC-mediated promotion of ectopic lymphoid organogenesis in the tumor microenvironment.

Weinstein AM, Chen L, Brzana EA, Patil PR, Taylor JL, Fabian KL, Wallace CT, Jones SD, Watkins SC, Lu B, Stroncek DF, Denning TL, Fu YX, Cohen PA, Storkus WJ.

Oncoimmunology. 2017 Apr 28;6(6):e1322238. doi: 10.1080/2162402X.2017.1322238. eCollection 2017.

31.

Risk of persistent or recurrent cervical neoplasia in patients with 'pure' adenocarcinoma-in-situ (AIS) or mixed AIS and high-grade cervical squamous neoplasia (cervical intra-epithelial neoplasia grades 2 and 3 (CIN 2/3)): a population-based study.

Codde E, Munro A, Stewart C, Spilsbury K, Bowen S, Codde J, Steel N, Leung Y, Tan J, Salfinger SG, Mohan GR, Cohen PA.

BJOG. 2018 Jan;125(1):74-79. doi: 10.1111/1471-0528.14808. Epub 2017 Aug 2.

32.

Variability in strength of red yeast rice supplements purchased from mainstream retailers.

Cohen PA, Avula B, Khan IA.

Eur J Prev Cardiol. 2017 Sep;24(13):1431-1434. doi: 10.1177/2047487317715714. Epub 2017 Jun 23.

PMID:
28641460
33.

Managing menopausal symptoms after breast cancer - A multidisciplinary approach.

Cohen PA, Brennan A, Marino JL, Saunders CM, Hickey M.

Maturitas. 2017 Nov;105:4-7. doi: 10.1016/j.maturitas.2017.04.013. Epub 2017 Apr 22. Review.

PMID:
28473176
34.

Prognostic Role of Histological Tumor Regression in Patients Receiving Neoadjuvant Chemotherapy for High-Grade Serous Tubo-ovarian Carcinoma.

Coghlan E, Meniawy TM, Munro A, Bulsara M, Stewart CJ, Tan A, Koay MHE, MaGee D, Codde J, Tan J, Salfinger SG, Mohan GR, Leung Y, Nichols CB, Cohen PA.

Int J Gynecol Cancer. 2017 May;27(4):708-713. doi: 10.1097/IGC.0000000000000945.

PMID:
28441251
35.

Fatigue and training of obstetrics and gynaecology trainees in Australia and New Zealand.

Tucker PE, Cohen PA, Bulsara MK, Acton J.

Aust N Z J Obstet Gynaecol. 2017 Oct;57(5):502-507. doi: 10.1111/ajo.12604. Epub 2017 Mar 26.

PMID:
28345217
36.

Review Article: Sexuality and Risk-Reducing Salpingo-oophorectomy.

Tucker PE, Cohen PA.

Int J Gynecol Cancer. 2017 May;27(4):847-852. doi: 10.1097/IGC.0000000000000943. Review.

PMID:
28333842
37.

Working hours of obstetrics and gynaecology trainees in Australia and New Zealand.

Acton J, Tucker PE, Bulsara MK, Cohen PA.

Aust N Z J Obstet Gynaecol. 2017 Oct;57(5):508-513. doi: 10.1111/ajo.12605. Epub 2017 Mar 15.

PMID:
28299774
38.

The critical role of the ZNF217 oncogene in promoting breast cancer metastasis to the bone.

Bellanger A, Donini CF, Vendrell JA, Lavaud J, Machuca-Gayet I, Ruel M, Vollaire J, Grisard E, Győrffy B, Bièche I, Peyruchaud O, Coll JL, Treilleux I, Maguer-Satta V, Josserand V, Cohen PA.

J Pathol. 2017 May;242(1):73-89. doi: 10.1002/path.4882. Epub 2017 Mar 27.

PMID:
28207159
39.

Risk of persistent or recurrent neoplasia in conservatively treated women with cervical adenocarcinoma in situ with negative histological margins.

Munro A, Codde J, Spilsbury K, Stewart CJ, Steel N, Leung Y, Tan J, Salfinger SG, Mohan GR, Semmens JB, Cohen PA.

Acta Obstet Gynecol Scand. 2017 Apr;96(4):432-437. doi: 10.1111/aogs.13110. Epub 2017 Mar 6.

PMID:
28181670
40.

Chemotherapy can induce weight normalization of morbidly obese mice despite undiminished ingestion of high fat diet.

Myers CE, Hoelzinger DB, Truong TN, Chew LA, Myles A, Chaudhuri L, Egan JB, Liu J, Gendler SJ, Cohen PA.

Oncotarget. 2017 Jan 17;8(3):5426-5438. doi: 10.18632/oncotarget.14576.

41.

Value of Specialist Pathology Review in a Single Statewide Gynecologic Cancer Service.

Melon J, Leung Y, Salfinger SG, Tan J, Mohan G, Cohen PA.

Int J Gynecol Cancer. 2017 Jan;27(1):171-176. doi: 10.1097/IGC.0000000000000834.

PMID:
28002209
42.

Surrogate in vitro activation of innate immunity synergizes with interleukin-7 to unleash rapid antigen-driven outgrowth of CD4+ and CD8+ human peripheral blood T-cells naturally recognizing MUC1, HER2/neu and other tumor-associated antigens.

Pathangey LB, McCurry DB, Gendler SJ, Dominguez AL, Gorman JE, Pathangey G, Mihalik LA, Dang Y, Disis ML, Cohen PA.

Oncotarget. 2017 Feb 14;8(7):10785-10808. doi: 10.18632/oncotarget.13911.

43.

Risk of persistent and recurrent cervical neoplasia following incidentally detected adenocarcinoma in situ.

Munro A, Codde J, Spilsbury K, Steel N, Stewart CJ, Salfinger SG, Tan J, Mohan GR, Leung Y, Semmens JB, O'Leary P, Williams V, Cohen PA.

Am J Obstet Gynecol. 2017 Mar;216(3):272.e1-272.e7. doi: 10.1016/j.ajog.2016.11.1044. Epub 2016 Nov 28.

PMID:
27908632
44.

Variability of Stimulant Levels in Nine Sports Supplements Over a 9-Month Period.

Attipoe S, Cohen PA, Eichner A, Deuster PA.

Int J Sport Nutr Exerc Metab. 2016 Oct;26(5):413-420. Epub 2016 Aug 24.

PMID:
26841433
45.

Long-term exposure to bisphenol A or benzo(a)pyrene alters the fate of human mammary epithelial stem cells in response to BMP2 and BMP4, by pre-activating BMP signaling.

Clément F, Xu X, Donini CF, Clément A, Omarjee S, Delay E, Treilleux I, Fervers B, Le Romancer M, Cohen PA, Maguer-Satta V.

Cell Death Differ. 2017 Jan;24(1):155-166. doi: 10.1038/cdd.2016.107. Epub 2016 Oct 14.

46.

The Supplement Paradox: Negligible Benefits, Robust Consumption.

Cohen PA.

JAMA. 2016 Oct 11;316(14):1453-1454. doi: 10.1001/jama.2016.14252. No abstract available.

PMID:
27727369
47.

Sexuality and quality of life in women with a prior diagnosis of breast cancer after risk-reducing salpingo-oophorectomy.

Tucker PE, Saunders C, Bulsara MK, Tan JJ, Salfinger SG, Green H, Cohen PA.

Breast. 2016 Dec;30:26-31. doi: 10.1016/j.breast.2016.08.005. Epub 2016 Sep 2.

PMID:
27592287
48.

Abnormal plasma DNA profiles in early ovarian cancer using a non-invasive prenatal testing platform: implications for cancer screening.

Cohen PA, Flowers N, Tong S, Hannan N, Pertile MD, Hui L.

BMC Med. 2016 Aug 24;14(1):126. doi: 10.1186/s12916-016-0667-6.

49.

Discussing Sexuality With Women Considering Risk-Reducing Salpingo-oophorectomy: An International Survey of Current Practice in Gynecologic Oncology.

Tucker PE, Bulsara MK, Salfinger SG, Tan JJ, Green H, Cohen PA.

Int J Gynecol Cancer. 2016 Sep;26(7):1338-44. doi: 10.1097/IGC.0000000000000750.

PMID:
27465883
50.

Definitive activation of endogenous antitumor immunity by repetitive cycles of cyclophosphamide with interspersed Toll-like receptor agonists.

Manrique SZ, Dominguez AL, Mirza N, Spencer CD, Bradley JM, Finke JH, Lee JJ, Pease LR, Gendler SJ, Cohen PA.

Oncotarget. 2016 Jul 12;7(28):42919-42942. doi: 10.18632/oncotarget.10190.

Supplemental Content

Loading ...
Support Center